DuLac Farmaceutici Expands U.S. Presence with Strategic Moves

Strategic Expansion into the U.S. Market

DuLac Farmaceutici, an esteemed Italian company with over three decades of pharmaceutical expertise, is embarking on an ambitious journey to expand its presence within the United States. By making their products available through OneLavi.com, DuLac is reaching broader e-commerce audiences and complementing its already established success on Amazon. This move signifies the company's dedication to building a comprehensive U.S. market strategy, combining consumer accessibility with strategic partnerships.

The significance of DuLac's expansion is further underscored by its upcoming participation in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida. This event is set to provide DuLac with a platform to engage directly with major U.S. retailers, a crucial step in forming relationships that could propel the company to new heights in the American market.

Building on Amazon Success

DuLac's journey into the American market began with the favorable reception of its products on Amazon U.S. The company's Arnica Gel 98% has garnered over 13,000 reviews with an impressive average rating of 4.5 stars, while the Dinaven line boasts more than 4,000 reviews with a 4.6-star average. This strong consumer feedback has paved the way for DuLac to explore additional channels, such as OneLavi.com, to further introduce its Italian-developed products to American consumers.

Founder and CEO Gabriele Bollani has expressed the company's commitment to the U.S. market, highlighting how these strategic moves demonstrate their intent to establish a lasting presence. By capitalizing on the consumer interest already shown on Amazon, DuLac is poised to expand its footprint and deepen its engagement with American consumers.

Introducing Italian Innovation at ECRM

DuLac's participation in the ECRM event marks a pivotal moment in its U.S. expansion strategy. Here, the company will have the opportunity to meet with key buyers from health, specialty, food, drug, and mass retail channels, presenting its unique product portfolio and pharmaceutical heritage. This includes highlighting their high-concentration Arnica Gel 98% range, as well as the Dinaven and Diosmin lines.

The objective for DuLac is not merely to secure additional distribution points but to forge lasting partnerships that will support a more diversified and extensive U.S. retail presence. With a focus on introducing their proprietary technologies such as Arnica Montana Arricchita™ and solvent-free Supercritical CO₂ Extraction, DuLac is set to showcase its commitment to quality and innovation.

As DuLac continues to expand, the combination of their established consumer base on Amazon, the new channel through OneLavi, and their strategic engagement with retailers at ECRM provides a robust foundation for growth. The company's dedication to bringing Italian pharmaceutical excellence to the U.S. market is evident, and their efforts to build a diverse and national presence are well underway. This journey of expansion not only underscores DuLac's strategic vision but also their commitment to delivering wellness solutions designed for active lifestyles and everyday well-being.